Benchling
@benchling
Followers
10K
Following
10K
Media
1K
Statuses
5K
On a mission to unlock the power of biotechnology and empower our global customers to get to milestones and market faster. Academics join for free! 🧫🧬👩🏻🔬
San Francisco, Boston, Zurich
Joined June 2012
What does it mean to be on #TeamScience? Find out what Benchlings have to say about our mission and culture — and above all, why we’re so passionate about helping scientists power new possibilities for humanity.
8
9
29
🚀 Bio x AI isn’t new… but 10 years ago, it was. @ekelsic saw the wave coming, and co-founded @Dyno_Tx. Now, he’s using #AI to solve in vivo gene delivery — and challenging the way biotech is built. 👉 Read his #Transcribed interview with @sajithw.
benchling.com
What if we could redesign biology itself to create molecules with outsized impact on human health? Dyno CEO Eric Kelsic shares how ML-designed AAV capsids are tackling the biggest challenge in gene...
0
0
2
“Most people aren’t really using that much #AI in R&D — yet.” On @NoPriorsPod, @sajithw talks about the concerns holding the industry back, and why the priority has to be building something that scientists trust and will actually use.
1
0
3
Aries is transforming logistics with modern tracking and unmatched client experience. Get a Quote or Book Now.
0
25
200
🤔 Do you think most people could name five biotech CEOs? @sajithw and @saranormous talk about why we need to tell scientists’ stories better. There are so many heroes behind each new drug, and we need to celebrate that more. 👏
0
0
2
👀 Stay tuned: support for additional target modalities coming soon!
0
1
4
⚡ Try it out today — an early preview of BoltzGen in Benchling! Using any amino acid sequence as a target, use BoltzGen to design binders of customizable length, and visualize the outputs directly in Benchling. #FeatureFriday #BenchlingAI
1
11
50
CipherOwl's SR3 stack: Screens 1million+ addresses per second Reasons with audit ready defensible output Provides report 10x output from compliance teams Research available in hours Book a demo to see how 5x your onchain compliance efficiency at 50% total cost of ownership
0
2
27
The last few years have been bleak in biotech. Yet, there's never been more excitement (and capital) around AI for scientific progress. How do you reconcile that? I recently sat down with @saranormous on @NoPriorsPod for a vibe check on biotech and how AI can help us get more
Sajith Wickramasekara, CEO of @benchling, argues that science’s complexity and specialization make it ideal for LLMs. AI can absorb the massive scientific corpus, provide expert level guidance, and remove the artisanal, inefficient parts of research that hold teams back.
4
7
27
Sajith Wickramasekara, CEO of @benchling, argues that science’s complexity and specialization make it ideal for LLMs. AI can absorb the massive scientific corpus, provide expert level guidance, and remove the artisanal, inefficient parts of research that hold teams back.
1
2
11
🎙️ Benchling CEO @sajithw joins @saranormous on @NoPriorsPod to discuss biotech’s “dot com” moment, why R&D remains slow and expensive, and how AI agents could finally speed up discovery and development. Full episode: https://t.co/6ZwBj3PwIq
1
4
6
💥 Incredible turnout for our event with Boltz! Over 100 scientists and R&D leaders came to meet BoltzGen co-creator @HannesStaerk and hear how the model was built. Missed it? Read our interview with Hannes: https://t.co/AczuKfLTjv
0
3
13
Our CRM was built for businesses that want to grow smarter.🌱 Automate tasks, manage leads, and close more deals!
13
17
277
📅 TOMORROW: Join us for a live chat with @HannesStaerk, co-creator of BoltzGen — one of the most exciting breakthroughs in generative protein design. Come to the Benchling office to meet Hannes, and see why the model is such a game changer. 👉 Save your spot:
0
3
10
📅 This week: @HannesStaerk shares how BoltzGen, the latest breakthrough generative protein design model, was built and validated. Join us at the Benchling office to discuss what this means for the future of biomolecular design! 👉 Don’t miss it: https://t.co/p4zdrtTeIG
0
8
49
We would be happy to have you at our BoltzGen launch event with Benchling in San Francisco with a presentation + discussion session! Thursday November 6th at 5pm: 680 Folsom St floor 10, San Francisco https://t.co/oxtflZ6b1M
luma.com
Join us at Benchling on Thursday, Nov. 6th, for details on the new model BoltzGen and discussions on the future of biomolecular design. Come hear from Hannes…
0
16
75
🎃 You know what’s scary? Spending hours manually copy-pasting data from PDFs (or even handwritten notes 😱). That’s why we built our Data Entry Agent, so you can turn messy files into clean, usable data in minutes. #BenchlingAI
0
0
0
🤔 Every biotech startup faces a key choice: build a platform or focus on a product. Over time, the industry has swung between the two. On #Transcribed, @ambellinger shares why Verve’s product-first focus brought in vivo editing to the clinic faster.
benchling.com
Cardiologist-turned-biotech leader Andrew Bellinger shares the bold bets, lessons, and leadership choices that shaped Verve's pioneering journey in gene editing — and what it takes to build first-i...
0
0
4
BoltzGen is coming to @benchling. We had a chance to sit down with the model co-creator @HannesStaerk to hear how BoltzGen was built, why transparent validation matters, and what sets this model apart. https://t.co/4OB2Axd9lC
benchling.com
Go "Behind the Model" with BoltzGen co-creator Hannes Stärk. Learn how Benchling and MIT built and validated BoltzGen for generative protein design, ensuring transparency and rigor in scientific AI.
Excited to release BoltzGen which brings SOTA folding performance to binder design! The best part of this project has been collaborating with many leading biologists who tested BoltzGen at an unprecedented scale, showing success on many novel targets and pushing its limits! 🧵..
0
5
36
👏 Congrats @HannesStaerk @GabriCorso and the entire team! We’re excited to partner with the Boltz team to bring BoltzGen, one of the world’s most advanced generative protein design models, into Benchling. ⚡ Design custom protein binders from any target with unprecedented speed
benchling.com
Go "Behind the Model" with BoltzGen co-creator Hannes Stärk. Learn how Benchling and MIT built and validated BoltzGen for generative protein design, ensuring transparency and rigor in scientific AI.
Excited to release BoltzGen which brings SOTA folding performance to binder design! The best part of this project has been collaborating with many leading biologists who tested BoltzGen at an unprecedented scale, showing success on many novel targets and pushing its limits! 🧵..
1
3
18
The picks and shovels of the AI economy. AIS provides exposure to companies at the forefront of artificial intelligence—spanning semiconductors, data centers, and AI-enabled applications. Consider how AIS may align with your investment strategy.
0
13
110
Thanks for having me on @sajithw ! Super fun conversation about one of my favorite topics
💉 Bold science starts with bold bets. @ambellinger, former CSO at @VerveTx, joins @sajithw on #Transcribed to talk focus, hiring, and building new drug modalities from scratch. 🎙️ Watch the full conversation. https://t.co/qL7QMCfXAf
0
1
4
Many scientists have told me @VerveTx is the best-run biotech they have ever worked at. I wanted to find out why. Very grateful to my friend @ambellinger for sitting down and sharing what made Verve special and lessons he learned as CSO. We covered: - Paying the pioneer's tax
3
2
9
💉 Bold science starts with bold bets. @ambellinger, former CSO at @VerveTx, joins @sajithw on #Transcribed to talk focus, hiring, and building new drug modalities from scratch. 🎙️ Watch the full conversation. https://t.co/qL7QMCfXAf
0
0
3